carvedilol has been researched along with Liver Dysfunction in 5 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "This prospective post-marketing drug use survey was conducted to assess the safety and efficacy of the β-adrenergic receptor antagonist (β-blocker) Artist® Tablets (carvedilol) in patients with hypertension in Japan." | 3.77 | Artist® tablets (carvedilol) for hypertensive patients in Japan: results of a drug use survey. ( Hiramatsu, K; Iizuka, T; Komiya, M; Matsumoto, T; Mori, Y; Nishikawa, Y; Zenimura, N, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 2 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dunne, PDJ | 1 |
| Young, D | 1 |
| Chuah, CS | 1 |
| Hayes, PC | 1 |
| Tripathi, D | 1 |
| Leithead, J | 1 |
| Smith, LA | 1 |
| Gaya, DR | 1 |
| Forrest, E | 1 |
| Stanley, AJ | 1 |
| Mohammed, SG | 1 |
| Ibrahim, IAAE | 1 |
| Mahmoud, MF | 1 |
| Mahmoud, AAA | 1 |
| Hassan, MI | 1 |
| Ali, FE | 1 |
| Shalkami, AS | 1 |
| Mori, Y | 1 |
| Nishikawa, Y | 1 |
| Iizuka, T | 1 |
| Zenimura, N | 1 |
| Matsumoto, T | 1 |
| Hiramatsu, K | 1 |
| Komiya, M | 1 |
| Drent, M | 1 |
| Gorgels, AP | 1 |
| Bast, A | 1 |
1 trial available for carvedilol and Liver Dysfunction
| Article | Year |
|---|---|
Carvedilol versus endoscopic band ligation for secondary prophylaxis of variceal bleeding-long-term follow-up of a randomised control trial.
Topics: Carvedilol; Esophageal and Gastric Varices; Follow-Up Studies; Gastrointestinal Hemorrhage; Humans; | 2022 |
4 other studies available for carvedilol and Liver Dysfunction
| Article | Year |
|---|---|
Carvedilol protects against hepatic ischemia/reperfusion injury in high-fructose/high-fat diet-fed mice: Role of G protein-coupled receptor kinase 2 and 5.
Topics: Animals; Carvedilol; Diet, High-Fat; Fructose; G-Protein-Coupled Receptor Kinase 2; G-Protein-Couple | 2019 |
Role of TLR-4/IL-6/TNF-α, COX-II and eNOS/iNOS pathways in the impact of carvedilol against hepatic ischemia reperfusion injury.
Topics: Adrenergic Antagonists; Animals; Anti-Inflammatory Agents; Carvedilol; Cyclooxygenase 2; Interleukin | 2021 |
Artist® tablets (carvedilol) for hypertensive patients in Japan: results of a drug use survey.
Topics: Adolescent; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and ove | 2011 |
Cardiac failure associated with G6PD deficiency.
Topics: Animals; Antioxidants; Carbazoles; Cardiac Output, Low; Carvedilol; Female; Glucosephosphate Dehydro | 2003 |